The role of mast cells in functional GI disorders

@article{Wouters2015TheRO,
  title={The role of mast cells in functional GI disorders},
  author={Mira M Wouters and Maria Vicario and Javier Santos},
  journal={Gut},
  year={2015},
  volume={65},
  pages={155 - 168}
}
Functional gastrointestinal disorders (FGIDs) are characterized by chronic complaints arising from disorganized brain-gut interactions leading to dysmotility and hypersensitivity. The two most prevalent FGIDs, affecting up to 16–26% of worldwide population, are functional dyspepsia and irritable bowel syndrome. Their etiopathogenic mechanisms remain unclear, however, recent observations reveal low-grade mucosal inflammation and immune activation, in association with impaired epithelial barrier… Expand
The Role of Mast Cells in Irritable Bowel Syndrome
TLDR
This review will focus on studies of the role of mast cell in IBS and the limitations of studies and will also consider future directions. Expand
Mast Cells and Irritable Bowel Syndrome: From the Bench to the Bedside
TLDR
This review focuses on recent advances in the role of mast cells in IBS, with particular emphasis on bridging experimental data with clinical therapeutics for IBS patients. Expand
Mast Cell May Be the Master Key to Solve the Mystery of Pathogenesis of Irritable Bowel Syndrome
TLDR
The authors found that mRNA expression of tryptase and PAR-2 was significantly elevated in the patients with IBS compared to the control, and the elevation of all neuropeptides in IBS-D only well corresponds with the results of some studies which showed mast cell hyperplasia is more common in Ibs-D. Expand
The role of intestinal mast cell infiltration in irritable bowel syndrome
TLDR
The associations between IBS and intestinal MC density and the underlying mechanisms are discussed and a better understanding about the pathological changes in the intestine is needed. Expand
Eosinophils in the gastrointestinal tract and their role in the pathogenesis of major colorectal disorders
TLDR
The author hypothesises that immune responses within colorectal mucus as well as ETosis exerted by both neutrophils and eosinophils on the both sides of the colonic epithelial barrier act as additional pathogenetic factors in IBD. Expand
Current insights into the innate immune system dysfunction in irritable bowel syndrome
TLDR
There is substantial evidence to support innate immune system dysfunction in several IBS phenotypes, but additional studies are required to better clarify the underlying pathogenetic pathways. Expand
Role of the Duodenum in the Pathogenesis of Functional Dyspepsia: A Paradigm Shift
TLDR
The hypothesis that FD is a disorder of microscopic small intestinal inflammation in a major subset is gaining acceptance, opening the possibility of novel treatment approaches that may be able to alter the natural history of the disorder. Expand
Gastric corticotropin-releasing factor influences mast cell infiltration in a rat model of functional dyspepsia
TLDR
The role of the CRF system in the pathogenesis of FD in a rat model is delineated and it is suggested that CRF may contribute to low grade inflammation via modulating mast cell infiltration, cytokine levels, MAPK signaling, and the gut-brain axis. Expand
Mucosal pathobiology and molecular signature of epithelial barrier dysfunction in the small intestine in irritable bowel syndrome
TLDR
The most recent findings on mucosal barrier alterations and its relationship to symptoms arising from the small intestine in IBS are summarized, including epithelial structural abnormalities, mucosal immune activation, and microbial dysbiosis, further supporting the hypothesis of an organic origin of IBS. Expand
Allergy and Neurogastroenterology
TLDR
This chapter aims to review the putative mechanisms for allergy in motility Disorders, including neuro-immune interactions, and review the available evidence for its role in the pathogenesis and treatment of common GI motility disorders. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 173 REFERENCES
Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions
TLDR
Functional and anatomical evidence for abnormal neuroimmune interactions has been found in patients with IBS and the link between immune alterations and severity of gastrointestinal symptoms and the positive effect of anti-inflammatory treatments in IBS further highlight the relevance of neuro immune interactions in this condition. Expand
Pathogenesis of irritable bowel syndrome: The mast cell connection
TLDR
This review focuses on the role of mast cells in IBS with particular emphasis on bridging experimental data on laboratory animals with pathological, clinical and epidemiological data on IBS patients. Expand
Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia
TLDR
It is suggested that impaired intestinal barrier function is a pathophysiological mechanism in FD and restoration of intestinal barrier integrity may be a potential therapeutic target for treating patients with FD. Expand
Increased humoral immunity in the jejunum of diarrhoea-predominant irritable bowel syndrome associated with clinical manifestations
TLDR
Enhanced small bowel humoral immunity is a distinctive feature of IBS-D, and mucosal Ig production contributes to local inflammation and clinical manifestations in I BS-D. Expand
Increased mast cells in the irritable bowel syndrome
  • O’Sullivan, Clayton, +4 authors O’morain
  • Medicine
  • Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society
  • 2000
TLDR
MC were significantly increased in the caecum of IBS patients compared to controls, suggesting that the multiple effects of the intestinal mast cell alone, or as a participant of a persistent inflammatory response, may be fundamental to the pathogenesis of Ibs. Expand
Combination of Allergic Factors Can Worsen Diarrheic Irritable Bowel Syndrome: Role of Barrier Defects and Mast Cells
TLDR
In IBS patients, the presence of an allergic background correlates with a more severe disease and diarrhea predominance, possibly by enhancing mucosal MC activation and paracellular permeability. Expand
Mucosal Immune Cell Numbers and Visceral Sensitivity in Patients With Irritable Bowel Syndrome: Is There Any Relationship?
TLDR
Although the number of mast cells, macrophages, T cells, and λFLC-positive mast cells is decreased in IBS compared with HV, this is not associated with the presence of visceral hypersensitivity or abnormal stress response. Expand
Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier
TLDR
The jejunal mucosa of IBS-D patients displays disrupted apical junctional complex integrity associated with mast cell activation and clinical manifestations, providing evidence for the organic nature of Ibs-D, a heretofore model disease of functional gastrointestinal disorders. Expand
Allergic Mastocytic Gastroenteritis and Colitis: An Unexplained Etiology in Chronic Abdominal Pain and Gastrointestinal Dysmotility
TLDR
It is suggested that in individuals with these characteristics, consideration should be given to staining their gastrointestinal biopsies for mast cells as this may provide them with relatively non-toxic but highly targeted treatment options. Expand
Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome.
TLDR
The role of the healthy intestinal epithelium as a barrier between the lumen and the rest of the body with a focus on tight junctions is summarized to explore how this increased permeability may elicit immune responses that affect afferent nerves, resulting in the pain associated with IBS. Expand
...
1
2
3
4
5
...